Welcome to the Wild, Wild West: the CGM head-to-head study
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
In the past at Diabettech, we’ve talked about how the design of a CGM safety and accuracy study plays a big part in the results […]
What impact does a botched rollout of an app update have on a CGM provider?
As I’m currently testing a Libre3, and have taken a look back at the various accuracy studies as a part of this to review MARD data, […]
The Libre2 has been available for some time now in both Germany and Norway, and is used by a reasonable number of loopers to drive […]
After running with the FreeStyle Libre with the MiaoMiao as a CGM system for two weeks, I’ve drawn some conclusions from use, although there’s a […]
As many people with T1D in the UK will know, there has been an ongoing dialogue between NHS England and the DVLA with respect to […]
The big question that remains for many more technical users in relation to the FreeStyle Libre 2 is whether it is transmitting glucose data or […]
If you live in the Social Media bubble for T1D in the UK, you can’t fail to have noticed that there was a press release […]
A little over two years ago, the Abbott Freestyle Libre launched, to much fanfare and significant consumer trialling and direct patient marketing (anyone see a […]
Today I’ve written about both the Triangle of Diabetes Care, which seems to be sponsored by Abbott, and the Libre accuracy study. These two components […]
Copyright © 2024 | WordPress Theme by MH Themes